Clarithromycin
is one of the newer macrolide which
possess better pharmacokinteic and
antimicrobial profiles unlike older
compounds like erythromycin.
Clarithromycin exhibits even
bactericidal activity against
Some
of the pathogens and even Post
Antibiotic Effect (PAE) which is not
seen with others. It has Good activity
against;
|
C.trachomatis
|
C.pneumoniae
|
M.catarhalis
|
|
H.influenzae
|
H.parainfluenzae
|
L.pneumophiliae
Etc.,
|
It
is very active against agents causing
atypical pneumonia like C.pneumoniae,
M.pneumoniae and markedly active
against L.pneumophiliae.
Similar
effects are also observed against
S.aureus, S.pyogenes and all strains
of S.pneumoniae and M.catarrhalis and
with GOOD against gram positive
anaerobes. With reference to
H.influenzae clarithromycin has twice
the activity of erythromycin ( c.f.
Azithromycin has increased activity
against gram negative organisms
particularly H.influenzae,
Enterobactericae, and unlike
Erythromycin & Clarithromycin it
has activity against Salmonellae,
Sigellae and E.coli).
Clarithromycin
has very good activity against agents
causing opportunistic infections
in AIDS patients
viz.,
MAC infection, Toxoplasmosis,
Cryptosporidiosis. Clarithromycin is
one of the second line drug
in M.leprae ( along with
minocycline). Recent studies have
shown that clarithromycin
is an effective agent against
M.chelonae which causes disseminated
cutaneous lesion and along with
Omeprazole (Better Lansoprazole)
clarithromycin
is effective in eradication of
H.pylori
in patients with peptic ulcer.
Very recent investigations revealed
the high efficacy of clarithromycin
against B.burgedorferi causing Lyme
disease.
It
is also effective against
Toxoplasmosis, and Cryptosporidiosis (c.f
Spiramycin).
None
of the existing Macrolides are
effective against MRSA and Enterococci.
Both clarithromycin and its 14 OH
metabolite exhibit synergistic
activity and PAE (post antibiotic
effect) and are bactericidal to
H.influenzae, S.pneumoniae,
M.catarrhalis, S.pyogenes,
S.agalectica. Clinical experience had
shown that Clarithromycin improves
immune function via its modulatory
effects on cytokine production
normalizes and/or improves
viscoelastic properties of mucus and
sputum and reduces sputum volume in
normal individuals too.